Department of Cardiovascular Surgery, Tokyo Medical University, Tokyo, Japan.
Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
J Endovasc Ther. 2022 Dec;29(6):866-873. doi: 10.1177/15266028211067738. Epub 2021 Dec 30.
The factors associated with aneurysm sac shrinkage after endovascular aneurysm repair (EVAR) are not well established. As inflammation is implicated in aneurysm pathophysiology, we hypothesized that high-sensitivity C-reactive protein (hsCRP) was associated with aneurysm sac shrinkage after EVAR and compared the preoperative level of hsCRP between patients with and without postoperative aneurysm sac shrinkage after EVAR.
From November 2013 to April 2019, 143 patients undergoing EVAR using Gore C3 Excluder (W. L. Gore & Associates, Inc, Flagstaff, Arizona) at our university hospital were included in this study. Aneurysm sac size was compared between that on baseline preoperative computed tomography (CT) and that on postoperative CT scans. A change in aneurysm sac size ≥5 mm was considered to be significant, whether due to enlargement or shrinkage.
Aneurysm sac size showed a significant decrease from 50.6 ± 9.8 mm to 47.1 ± 10.3 mm at 1 year. At 1 year postoperatively, aneurysm sac shrinkage (≥5 mm) was observed in 48 patients (34%), a stable aneurysm sac was noted in 93 patients (65%), and aneurysm sac enlargement was noted in 2 patients (1.4%). The mean preoperative hsCRP was 0.33 ± 0.54 mg/dL. Univariable analysis showed that preoperative hsCRP (p=0.029) and the presence of a renal cyst (p=0.002) were associated with aneurysm sac shrinkage. Multivariable analysis showed that preoperative hsCRP [>0.19mg/dL] (odds ratio [OR] = 0.22; 95% confidence interval [CI] = 0.05-0.96; p=0.042), and the presence of a renal cyst (OR = 0.31; 95% CI = 0.15-0.67; p=0.002) were independent risk factors for aneurysm sac shrinkage after EVAR.
The level of preoperative hsCRP was independently associated with aneurysm sac shrinkage after EVAR in patients with abdominal aortic aneurysms. These data suggest that the high level of hsCRP can be a negative predictor for aneurysm sac shrinkage after EVAR.
血管内动脉瘤修复术(EVAR)后动脉瘤囊缩小的相关因素尚不清楚。由于炎症与动脉瘤病理生理学有关,我们假设高敏 C 反应蛋白(hsCRP)与 EVAR 后动脉瘤囊缩小有关,并比较了 EVAR 后动脉瘤囊缩小和未缩小患者的术前 hsCRP 水平。
本研究纳入了 2013 年 11 月至 2019 年 4 月在我院行 Gore C3 Excluder(W. L. Gore & Associates,Inc.,Flagstaff,Arizona)EVAR 的 143 例患者。比较基线术前计算机断层扫描(CT)和术后 CT 扫描的动脉瘤囊大小。动脉瘤囊大小增加≥5mm 被认为是显著的,无论是增大还是缩小。
动脉瘤囊大小从 50.6±9.8mm 显著减小至 47.1±10.3mm(1 年)。术后 1 年,48 例(34%)患者出现动脉瘤囊缩小(≥5mm),93 例(65%)患者动脉瘤囊稳定,2 例(1.4%)患者动脉瘤囊增大。术前 hsCRP 的平均水平为 0.33±0.54mg/dL。单变量分析显示,术前 hsCRP(p=0.029)和肾囊肿的存在(p=0.002)与动脉瘤囊缩小有关。多变量分析显示,术前 hsCRP(>0.19mg/dL)(比值比[OR] = 0.22;95%置信区间[CI] = 0.05-0.96;p=0.042)和肾囊肿的存在(OR = 0.31;95%CI = 0.15-0.67;p=0.002)是 EVAR 后动脉瘤囊缩小的独立危险因素。
在腹主动脉瘤患者中,术前 hsCRP 水平与 EVAR 后动脉瘤囊缩小独立相关。这些数据表明,hsCRP 水平升高可能是 EVAR 后动脉瘤囊缩小的负预测因子。